Keywords: UK, NICE, Novartis, Glivec, Gleevec, GIST

UK’s NICE “not minded” to recommend Novartis’ Glivec/Gleevec for GIST patients at risk of recurrence after surgery

Article | 24 March 2010

Print This

The UK’s National Institute for Health and Clinical Excellence (NICE) has given its preliminary view that it is “minded ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in